Literature DB >> 12487627

Characterization of Streptococcus pneumoniae enoyl-(acyl-carrier protein) reductase (FabK).

Hedia Marrakchi1, Walter E Dewolf, Chad Quinn, Joshua West, Brian J Polizzi, Chi Y So, David J Holmes, Shannon L Reed, Richard J Heath, David J Payne, Charles O Rock, Nicola G Wallis.   

Abstract

The enoyl-(acyl-carrier protein) (ACP) reductase catalyses the last step in each cycle of fatty acid elongation in the type II fatty acid synthase systems. An extensively characterized NADH-dependent reductase, FabI, is widely distributed in bacteria and plants, whereas the enoyl-ACP reductase, FabK, is a distinctly different member of this enzyme group discovered in Streptococcus pneumoniae. We were unable to delete the fabK gene from Strep. pneumoniae, suggesting that this is the only enoyl-ACP reductase in this organism. The FabK enzyme was purified and the biochemical properties of the reductase were examined. The visible absorption spectrum of the purified protein indicated the presence of a flavin cofactor that was identified as FMN by MS, and was present in a 1:1 molar ratio with protein. FabK specifically required NADH and the protein activity was stimulated by ammonium ions. FabK also exhibited NADH oxidase activity in the absence of substrate. Strep. pneumoniae belongs to the Bacillus / Lactobacillus / Streptococcus group that includes Staphylococcus aureus and Bacillus subtilis. These two organisms also contain FabK-related genes, suggesting that they may also express a FabK-like enoyl-ACP reductase. However, the genes did not complement a fabI (Ts) mutant and the purified flavoproteins were unable to reduce enoyl-ACP in vitro and did not exhibit NAD(P)H oxidase activity, indicating they were not enoyl-ACP reductases. The restricted occurrence of the FabK enoyl-ACP reductase may be related to the role of substrate-independent NADH oxidation in oxygen-dependent anaerobic energy metabolism.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12487627      PMCID: PMC1223239          DOI: 10.1042/BJ20021699

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  26 in total

1.  A triclosan-resistant bacterial enzyme.

Authors:  R J Heath; C O Rock
Journal:  Nature       Date:  2000-07-13       Impact factor: 49.962

2.  A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.

Authors:  M M Bradford
Journal:  Anal Biochem       Date:  1976-05-07       Impact factor: 3.365

3.  Contribution of NADH oxidase to aerobic metabolism of Streptococcus pyogenes.

Authors:  C M Gibson; T C Mallett; A Claiborne; M G Caparon
Journal:  J Bacteriol       Date:  2000-01       Impact factor: 3.490

4.  Crystallographic analysis of triclosan bound to enoyl reductase.

Authors:  A Roujeinikova; C W Levy; S Rowsell; S Sedelnikova; P J Baker; C A Minshull; A Mistry; J G Colls; R Camble; A R Stuitje; A R Slabas; J B Rafferty; R A Pauptit; R Viner; D W Rice
Journal:  J Mol Biol       Date:  1999-11-26       Impact factor: 5.469

5.  Preparative enzymatic synthesis and hydrophobic chromatography of acyl-acyl carrier protein.

Authors:  C O Rock; J L Garwin
Journal:  J Biol Chem       Date:  1979-08-10       Impact factor: 5.157

6.  A genomic analysis of two-component signal transduction in Streptococcus pneumoniae.

Authors:  J P Throup; K K Koretke; A P Bryant; K A Ingraham; A F Chalker; Y Ge; A Marra; N G Wallis; J R Brown; D J Holmes; M Rosenberg; M K Burnham
Journal:  Mol Microbiol       Date:  2000-02       Impact factor: 3.501

7.  Inhibition of the Staphylococcus aureus NADPH-dependent enoyl-acyl carrier protein reductase by triclosan and hexachlorophene.

Authors:  R J Heath; J Li; G E Roland; C O Rock
Journal:  J Biol Chem       Date:  2000-02-18       Impact factor: 5.157

8.  Triclosan and antibiotic resistance in Staphylococcus aureus.

Authors:  M T Suller; A D Russell
Journal:  J Antimicrob Chemother       Date:  2000-07       Impact factor: 5.790

9.  The enoyl-[acyl-carrier-protein] reductases FabI and FabL from Bacillus subtilis.

Authors:  R J Heath; N Su; C K Murphy; C O Rock
Journal:  J Biol Chem       Date:  2000-12-22       Impact factor: 5.157

10.  Molecular cloning and analysis of the gene encoding the NADH oxidase from Streptococcus faecalis 10C1. Comparison with NADH peroxidase and the flavoprotein disulfide reductases.

Authors:  R P Ross; A Claiborne
Journal:  J Mol Biol       Date:  1992-10-05       Impact factor: 5.469

View more
  52 in total

Review 1.  Fatty acid biosynthesis revisited: structure elucidation and metabolic engineering.

Authors:  Joris Beld; D John Lee; Michael D Burkart
Journal:  Mol Biosyst       Date:  2014-10-31

2.  Structural and enzymatic analyses reveal the binding mode of a novel series of Francisella tularensis enoyl reductase (FabI) inhibitors.

Authors:  Shahila Mehboob; Kirk E Hevener; Kent Truong; Teuta Boci; Bernard D Santarsiero; Michael E Johnson
Journal:  J Med Chem       Date:  2012-06-08       Impact factor: 7.446

Review 3.  The reductase steps of the type II fatty acid synthase as antimicrobial targets.

Authors:  Yong-Mei Zhang; Ying-Jie Lu; Charles O Rock
Journal:  Lipids       Date:  2004-11       Impact factor: 1.880

Review 4.  Antibacterial targets in fatty acid biosynthesis.

Authors:  H Tonie Wright; Kevin A Reynolds
Journal:  Curr Opin Microbiol       Date:  2007-08-17       Impact factor: 7.934

5.  Resistance to AFN-1252 arises from missense mutations in Staphylococcus aureus enoyl-acyl carrier protein reductase (FabI).

Authors:  Jiangwei Yao; John B Maxwell; Charles O Rock
Journal:  J Biol Chem       Date:  2013-11-04       Impact factor: 5.157

6.  Genome of the opportunistic pathogen Streptococcus sanguinis.

Authors:  Ping Xu; Joao M Alves; Todd Kitten; Arunsri Brown; Zhenming Chen; Luiz S Ozaki; Patricio Manque; Xiuchun Ge; Myrna G Serrano; Daniela Puiu; Stephanie Hendricks; Yingping Wang; Michael D Chaplin; Doruk Akan; Sehmi Paik; Darrell L Peterson; Francis L Macrina; Gregory A Buck
Journal:  J Bacteriol       Date:  2007-02-02       Impact factor: 3.490

7.  Structural characterization of Porphyromonas gingivalis enoyl-ACP reductase II (FabK).

Authors:  Kirk E Hevener; Bernard D Santarsiero; Hyun Lee; Jesse A Jones; Teuta Boci; Michael E Johnson; Shahila Mehboob
Journal:  Acta Crystallogr F Struct Biol Commun       Date:  2018-01-26       Impact factor: 1.056

8.  AG205, a novel agent directed against FabK of Streptococcus pneumoniae.

Authors:  Sho Takahata; Maiko Iida; Yumi Osaki; Jun Saito; Hideo Kitagawa; Tomohiro Ozawa; Takuji Yoshida; Shigeru Hoshiko
Journal:  Antimicrob Agents Chemother       Date:  2006-08       Impact factor: 5.191

Review 9.  Is bacterial fatty acid synthesis a valid target for antibacterial drug discovery?

Authors:  Joshua B Parsons; Charles O Rock
Journal:  Curr Opin Microbiol       Date:  2011-08-20       Impact factor: 7.934

Review 10.  Bacterial fatty acid metabolism in modern antibiotic discovery.

Authors:  Jiangwei Yao; Charles O Rock
Journal:  Biochim Biophys Acta Mol Cell Biol Lipids       Date:  2016-09-23       Impact factor: 4.698

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.